Skip to main content

Table 2 Apolipoproteins after oral fat tolerance test in native and in chylomicron-free serum

From: Apolipoprotein CIII predicts cardiovascular events in patients with coronary artery disease: a prospective observational study

 

ApoAI

ApoAII

ApoB

ApoCII

ApoCIII

ApoE

Native Serum

 0 h

134.2 (26.4)

37.0 (8.5)

82.6 (24.9)

3.1 (1.4)

10.0 (3.7)

11.5 (3.2)

 5 h

132.3 (25.1)

36.9 (8.7)

81.1 (25.2)

3.2 (1.5)

10.2 (3.9)

11.8 (3.4)

 Absolute change (mg/dL)

−1.9 (15.0)

−0.2 (3.6)

−1.4 (8.4)

0.0 (0.6)

0.2 (1.5)

0.4 (1.4)

 Proportional change (%)

−0.6 (13.5)

−0.1 (10.6)

−1.4 (9.7)

1.8 (24.0)

3.7 (23.1)

3.6 (12.6)

P value

0.076

0.402a

0.019

0.953a

0.122a

0.001a

Chylomicron-free serum

 0 h

122.1 (26.8)

32.3 (8.5)

57.3 (20.7)

2.4 (1.2)

7.5 (4.1)

9.6 (2.9)

 5 h

121.4 (26.9)

32.0 (8.3)

55.1 (20.1)

2.2 (1.1)

7.3 (4.2)

9.4 (2.8)

 Absolute change (mg/dL)

−0.7 (19.7)

−0.4 (5.0)

−2.3 (9.2)

−0.2 (0.6)

−0.2 (1.9)

−0.2 (1.6)

 Proportional change (%)

−0.5 (15.9)

−0.2 (18.0)

−1.8 (26.3)

−0.6 (31.4)

−0.6 (37.4)

−0.0 (17.8)

P value

0.622

0.268

0.001

<  0.001a

0.288

0.190

  1. Values are in mg/dL and presented as mean (standard deviation) if not stated otherwise. h hours. a Wilcoxon test, otherwise t test